BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

Clinical trial NCT00904839 · COMPLETED

Trial details

NCT number: NCT00904839
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2009-05-01
Primary completion: 2012-01-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.